Surya Pharmaceutical Limited

Surya Pharmaceutical Limited - healthcare in Delhi, India. Directors, charges & compliance details.
CIN L24232DL1992PLC227186 Incorporated 25 March 1992 ROC Delhi HQ Delhi, India
Under Liquidation Listed Public Limited Company healthcare
Data last updated
Authorised capital
₹100 Cr
Registered with MCA
Paid-up capital
₹20.28 Cr
Issued & subscribed
Open charges
₹4,828.13 Cr
Satisfied ₹1,682.69 Cr
Company age
34 yrs
Est. 1992
Directors on board
4
As per MCA filings
Key managerial staff
1
CEO, CFO, company secretary
Active GSTINs
3
of 12 registered
Brands
2
Associated brands

About Surya Pharmaceutical Limited

Data last updated:

Surya Pharmaceutical Limited is a public limited company based in Delhi, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 25 March 1992.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN L24232DL1992PLC227186. Its GSTIN is 04AABCS3001K2ZU (Chandigarh). The company holds 12 GST registrations, of which 3 are active. It is recorded as listed by MCA, but its shares were delisted from BSE on 11 May 2018 · compulsory delisting, and no longer trade on a stock exchange.

The company has an authorised share capital of ₹100 Cr and a paid-up capital of ₹20.28 Cr. It is led by directors including Rajiv Goyal (Managing Director) and Alka Goyal (Whole-Time Director).

Its last annual general meeting (AGM) was held on 29 September 2014, and its latest financial statements are for the year ended 31 March 2014. The registered office is at 1596 1st Floor Bhagirath Palace Chandni Chownk, Delhi, India – 110006.

The company is associated with 2 brands: Surya Pharmaceutical and Suryapharma. As per MCA filings, the company has open charges of ₹4,828.13 Cr and satisfied charges of ₹1,682.69 Cr on record. Court records list 80 cases involving the company, including 35 filed by the company and 45 filed against it; 9 cases are pending.

The last known website on record is suryapharma.in.

Company details

CIN L24232DL1992PLC227186
Registration Number 227186
Incorporation Date 25 March 1992
ROC Delhi
Listing Status Listed - Delisted from BSE on 11 May 2018 · compulsory delisting
Company Status Under Liquidation
Date of Last AGM 29 September 2014
Date of Balance Sheet 31 March 2014
Compliance Status Active Non-Compliant

CIN history

Surya Pharmaceutical has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24232DL1992PLC227186, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L24232DL1992PLC227186Current
U24232HP1992PLC023861Previous
L24232HP1992PLC023861Previous

Contact details

Surya Pharmaceutical Limited's registered office is in Delhi, Delhi.

  • Social Media
  • Registered Address
    1596 1st Floor Bhagirath Palace Chandni Chownk, Delhi, India – 110006
  • Industry
    Healthcare, Ayurvedic Products & Services
Comprehensive company report
Surya Pharmaceutical Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Surya Pharmaceutical operates two associated brands: Surya Pharmaceutical and Suryapharma. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturer and supplier of finished formulations and API'ssuryapharma.com
Scientifically validated polyherbal and Ayurvedic products are manufactured.suryapharma.in

Financials of Surya Pharmaceutical Limited

FY 2014 filings available

Financial Statement Summary

MetricsFY 2013-14
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2013-14
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Surya Pharmaceutical Limited, buy the company report.

Board of directors and KMP of Surya Pharmaceutical Limited

Surya Pharmaceutical Limited currently reports 3 directors and 1 key managerial person. 16 former directors have served the organization.

Directors and KMP (as last reported)
NameDesignationAppointment DateTenureStatus
Alka GoyalWhole-Time Director24 Aug 199630 Years 1 MonthsAs last reported
Jasvinder SinghAdditional Director10 Oct 201313 Years 0 MonthsAs last reported
Bharat JainCompany Secretary16 Jun 201214 Years 4 MonthsAs last reported
Rajiv GoyalManaging Director25 Mar 199234 Years 6 MonthsAs last reported

Charges & borrowings

Open charges
₹4,828.13 Cr
Satisfied charges
₹1,682.69 Cr
Breakdown by lending institutions
State Bank of India₹3,548.64 Cr
Edelweiss Asset Reconstruction Company Limited₹435.50 Cr
Punjab National Bank₹145.99 Cr
Bank of Baroda₹125.00 Cr
Allahabad Bank₹115.00 Cr
Others₹458.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Feb 201310421669State Bank of India₹546.44 CrOpen
31 Dec 201210406810Punjab National Bank₹135.99 CrOpen
14 Feb 201210335392Idbi Bank Limited₹60 CrOpen
05 Jan 201210330932Punjab National Bank₹5 CrOpen
02 Nov 201110319478Punjab National Bank₹5 CrOpen

To see the full charge records of Surya Pharmaceutical Limited, buy the company report.

Total charge records: 80 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Surya Pharmaceutical Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Surya Pharmaceutical has 12 GST registrations: 3 active and 9 cancelled or inactive.

Total GSTINs
12
Active
3
Cancelled / inactive
9
GSTINStateStatusRegistered on
04AABCS3001K2ZUChandigarhActive06 Dec 2018
03AABCS3001K2ZWPunjabActive21 Mar 2020
06AABCS3001K2ZQHaryanaActive25 Mar 2020

To see the full GST registrations and return filing status of Surya Pharmaceutical Limited, buy the company report.

Recent activity

Surya Pharmaceutical Limited has 34 board changes on record since 1992: 19 appointments and 15 cessations. The latest: Jasvinder Singh was appointed as Additional Director on 10 Oct 2013.

AGM
Surya Pharmaceutical Limited last Annual general meeting of members was held on 29 Sep 2014 as per latest MCA records.
Filing
Surya Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Delhi.
Charges
A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 2.50 Cr registered on 12 Nov 2008 with Charge ID 10132676 was modified on 26 Mar 2014.
Charges
A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 3.00 Cr registered on 20 Sep 2007 with Charge ID 10068728 was modified on 26 Mar 2014.
Charges
A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 100.00 Cr registered on 13 Oct 2004 with Charge ID 90312128 was modified on 26 Mar 2014.
Charges
A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 30.00 Cr registered on 19 Jan 2011 with Charge ID 10260867 was modified on 31 Dec 2013.
Charges
A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 30.00 Cr registered on 16 Jul 2010 with Charge ID 10228213 was modified on 31 Dec 2013.
Charges
A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 100.00 Cr registered on 03 Feb 2010 with Charge ID 10201549 was modified on 31 Dec 2013.
Charges
A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 50.00 Cr registered on 23 Dec 2008 with Charge ID 10138327 was modified on 31 Dec 2013.
Charges
A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 120.00 Cr registered on 05 Feb 2008 with Charge ID 10086237 was modified on 31 Dec 2013.
Appointed
Jasvinder Singh was appointed as Additional Director.
Ceased
Dharam Pal Singhal ceased to be Director.

189 earlier events are in the company report.

Frequently asked questions

Surya Pharmaceutical is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.

Surya Pharmaceutical is a company under liquidation, formerly operating as a public limited company based in Delhi, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 25 March 1992 and is registered under CIN L24232DL1992PLC227186. Caution is advised - the company may not have the legal capacity to fulfil new agreements.

Surya Pharmaceutical has 4 current directors and KMP:

The latest financial statements of Surya Pharmaceutical on record with the MCA are for the year ended 31 March 2014. Its last annual general meeting was held on 29 September 2014. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Surya Pharmaceutical is L24232DL1992PLC227186. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Surya Pharmaceutical is recorded as a listed company by MCA, but its shares were delisted from BSE on 11 May 2018 · compulsory delisting, and no longer trade on a stock exchange.

Surya Pharmaceutical has open charges of ₹4,828.13 Cr and satisfied charges of ₹1,682.69 Cr as per latest MCA filings.

Surya Pharmaceutical has 80 court cases on record: 35 filed by the company and 45 filed against it. 9 are pending. Most are in the district courts.

Surya Pharmaceutical was incorporated on 25 March 1992. It is registered with the Registrar of Companies, Delhi.

Jasvinder Singh was appointed as Additional Director on 10 Oct 2013. Dharam Pal Singhal ceased to be Director on 15 Jun 2013. Subhash Chander Marwaha ceased to be Nominee Director on 29 May 2013. Surya Pharmaceutical has 34 board changes on record in total.